MANNKIND CORP Increase (Decrease) in Accounts Payable
MANNKIND CORP (MNKD) reported Increase (Decrease) in Accounts Payable of $1.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- MANNKIND CORP increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$5.12M, a 198.12% decline year-over-year.
- MANNKIND CORP increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $7.11M.
- MANNKIND CORP increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$17.19M, a 5039.08% decline year-over-year.
- MANNKIND CORP increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.99M.
- MANNKIND CORP increase (decrease) in accounts payable for fiscal 2025 was -$16.71M.
- MANNKIND CORP increase (decrease) in accounts payable for fiscal 2024 was -$2.79M.
- MANNKIND CORP increase (decrease) in accounts payable for fiscal 2023 was -$1.47M, a 135.96% decline from fiscal 2022.
- MANNKIND CORP increase (decrease) in accounts payable for fiscal 2022 was $4.10M, a 198.11% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 244 month | Increase (Decrease) in Accounts Payable 247 month | Increase (Decrease) in Accounts Payable 250 month | Increase (Decrease) in Accounts Payable 253 month | Increase (Decrease) in Accounts Payable 256 month | Increase (Decrease) in Accounts Payable 259 month | Increase (Decrease) in Accounts Payable 263 month | Increase (Decrease) in Accounts Payable 265 month | Increase (Decrease) in Accounts Payable 268 month | Increase (Decrease) in Accounts Payable 271 month | Increase (Decrease) in Accounts Payable 275 month | Increase (Decrease) in Accounts Payable 277 month | Increase (Decrease) in Accounts Payable 280 month | Increase (Decrease) in Accounts Payable 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.99M 10-Q · filed 2026-08-05 | -$15.20M derived: sum of 3 quarters · filed 2026-08-05 | -$18.18M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2026-03-31 | $7.11M 10-Q · filed 2026-05-06 | -$10.08M derived: sum of 2 quarters · filed 2026-05-06 | -$13.07M derived: sum of 3 quarters · filed 2026-05-06 | -$7.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-12-31 | -$17.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$20.18M derived: sum of 2 quarters · filed 2026-02-26 | -$14.96M derived: sum of 3 quarters · filed 2026-08-05 | -$16.71M 10-K · filed 2026-02-26 | ||||||||||||||
| 2025-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.23M derived: sum of 2 quarters · filed 2026-08-05 | $477.00K 10-Q · filed 2025-11-05 | $825.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-06-30 | $5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.46M 10-Q · filed 2026-08-05 | $3.81M derived: sum of 3 quarters · filed 2026-08-05 | $701.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-03-31 | -$1.75M 10-Q · filed 2026-05-06 | -$1.40M derived: sum of 2 quarters · filed 2026-05-06 | -$4.51M derived: sum of 3 quarters · filed 2026-05-06 | -$2.11M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||||
| 2024-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.76M derived: sum of 2 quarters · filed 2026-02-26 | -$357.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.79M 10-K · filed 2026-02-26 | ||||||||||||||
| 2024-09-30 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$705.00K derived: sum of 2 quarters · filed 2025-11-05 | -$3.14M 10-Q · filed 2025-11-05 | -$10.31M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$24.00K 10-Q · filed 2025-08-06 | -$7.20M derived: sum of 3 quarters · filed 2026-02-26 | -$7.57M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-03-31 | -$2.43M 10-Q · filed 2025-05-08 | -$9.61M derived: sum of 2 quarters · filed 2026-02-26 | -$9.98M derived: sum of 3 quarters · filed 2026-02-26 | -$6.74M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2023-12-31 | -$7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$7.55M derived: sum of 2 quarters · filed 2026-02-26 | -$4.31M derived: sum of 3 quarters · filed 2026-02-26 | -$1.47M 10-K · filed 2026-02-26 | ||||||||||||||
| 2023-09-30 | -$373.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.87M derived: sum of 2 quarters · filed 2024-11-07 | $5.70M 10-Q · filed 2024-11-07 | $6.88M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.08M 10-Q · filed 2024-08-07 | $7.25M derived: sum of 3 quarters · filed 2025-02-26 | $9.30M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-03-31 | $2.84M 10-Q · filed 2024-05-08 | $4.02M derived: sum of 2 quarters · filed 2025-02-26 | $6.07M derived: sum of 3 quarters · filed 2025-02-26 | $5.19M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.23M derived: sum of 2 quarters · filed 2025-02-26 | $2.35M derived: sum of 3 quarters · filed 2025-02-26 | $4.10M 10-K · filed 2025-02-26 | ||||||||||||||
| 2022-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.17M derived: sum of 2 quarters · filed 2023-11-07 | $2.92M 10-Q · filed 2023-11-07 | $344.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-06-30 | -$878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $867.00K 10-Q · filed 2023-08-07 | -$1.71M derived: sum of 3 quarters · filed 2024-02-27 | $337.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-03-31 | $1.75M 10-Q · filed 2023-05-09 | -$827.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.22M derived: sum of 3 quarters · filed 2024-02-27 | $2.00M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2021-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$530.00K derived: sum of 2 quarters · filed 2024-02-27 | $250.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.37M 10-K · filed 2024-02-27 | ||||||||||||||
| 2021-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.82M derived: sum of 2 quarters · filed 2022-11-08 | $3.95M 10-Q · filed 2022-11-08 | $3.73M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-06-30 | $780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.90M 10-Q · filed 2022-08-09 | $1.69M derived: sum of 3 quarters · filed 2023-02-23 | $1.67M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-03-31 | $1.12M 10-Q · filed 2022-05-05 | $909.00K derived: sum of 2 quarters · filed 2023-02-23 | $885.00K derived: sum of 3 quarters · filed 2023-02-23 | -$25.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2020-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$239.00K derived: sum of 2 quarters · filed 2023-02-23 | -$1.15M derived: sum of 3 quarters · filed 2023-02-23 | $793.00K 10-K · filed 2023-02-23 | ||||||||||||||
| 2020-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$934.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.01M 10-Q · filed 2021-11-09 | -$5.87M derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||||
| 2020-06-30 | -$910.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.03M 10-Q · filed 2021-08-11 | -$5.84M derived: sum of 3 quarters · filed 2021-08-11 | -$1.72M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||
| 2020-03-31 | $1.94M 10-Q · filed 2021-05-12 | -$4.93M derived: sum of 2 quarters · filed 2021-05-12 | -$805.00K derived: sum of 3 quarters · filed 2021-05-12 | -$250.00K derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||
| 2019-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.75M derived: sum of 2 quarters · filed 2021-02-25 | -$2.19M derived: sum of 3 quarters · filed 2021-02-25 | -$593.00K 10-K · filed 2021-02-25 | ||||||||||||||
| 2019-09-30 | $4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $4.68M derived: sum of 2 quarters · filed 2020-11-04 | $6.28M 10-Q · filed 2020-11-04 | $5.85M derived: sum of 4 quarters · filed 2020-11-04 | ||||||||||||||
| 2019-06-30 | $555.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.15M 10-Q · filed 2020-08-05 | $1.72M derived: sum of 3 quarters · filed 2020-08-05 | -$1.70M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | $1.60M 10-Q · filed 2020-05-06 | $1.16M derived: sum of 2 quarters · filed 2020-05-06 | -$2.26M derived: sum of 3 quarters · filed 2020-05-06 | $2.00M derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||||
| 2018-12-31 | -$436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$3.86M derived: sum of 2 quarters · filed 2020-02-25 | $403.00K derived: sum of 3 quarters · filed 2020-02-25 | -$1.60M 10-K · filed 2020-02-25 | ||||||||||||||
| 2018-09-30 | -$3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $839.00K derived: sum of 2 quarters · filed 2019-11-08 | -$1.17M 10-Q · filed 2019-11-08 | $532.00K derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.25M 10-Q · filed 2019-08-07 | $3.95M derived: sum of 3 quarters · filed 2019-08-07 | $2.70M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||||
| 2018-03-31 | -$2.01M 10-Q · filed 2019-05-07 | -$307.00K derived: sum of 2 quarters · filed 2019-05-07 | -$1.56M derived: sum of 3 quarters · filed 2019-05-07 | $3.46M derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||||||
| 2017-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $443.00K derived: sum of 2 quarters · filed 2019-02-26 | $5.46M derived: sum of 3 quarters · filed 2019-02-26 | $3.80M 10-K · filed 2019-02-26 | ||||||||||||||
| 2017-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.76M derived: sum of 2 quarters · filed 2018-11-01 | $2.10M 10-Q · filed 2018-11-01 | $269.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2017-06-30 | $5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $3.36M 10-Q · filed 2018-08-02 | $1.53M derived: sum of 3 quarters · filed 2019-02-26 | $3.77M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2017-03-31 | -$1.67M 10-Q · filed 2018-05-09 | -$3.50M derived: sum of 2 quarters · filed 2019-02-26 | -$1.25M derived: sum of 3 quarters · filed 2019-02-26 | $1.02M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2016-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $414.00K derived: sum of 2 quarters · filed 2019-02-26 | $2.68M derived: sum of 3 quarters · filed 2019-02-26 | -$12.12M 10-K · filed 2019-02-26 | ||||||||||||||
| 2016-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.51M derived: sum of 2 quarters · filed 2017-11-07 | -$10.29M 10-Q · filed 2017-11-07 | $823.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2016-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$12.53M 10-Q · filed 2017-08-07 | -$1.42M derived: sum of 3 quarters · filed 2018-02-27 | -$1.88M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2016-03-31 | -$14.80M 10-Q · filed 2017-05-10 | -$3.69M derived: sum of 2 quarters · filed 2018-02-27 | -$4.15M derived: sum of 3 quarters · filed 2018-02-27 | -$2.20M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2015-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.65M derived: sum of 2 quarters · filed 2018-02-27 | $12.60M derived: sum of 3 quarters · filed 2018-02-27 | $8.41M 10-K · filed 2018-02-27 | ||||||||||||||
| 2015-09-30 | -$462.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $1.48M derived: sum of 2 quarters · filed 2016-11-09 | -$2.70M 10-Q · filed 2016-11-09 | -$12.77M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | $1.95M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | -$2.24M 10-Q/A · filed 2016-08-10 | -$12.31M derived: sum of 3 quarters · filed 2017-03-16 | -$181.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | -$4.18M 10-Q · filed 2016-05-09 | -$14.25M derived: sum of 2 quarters · filed 2017-03-16 | -$2.13M derived: sum of 3 quarters · filed 2017-03-16 | $478.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | -$10.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.06M derived: sum of 2 quarters · filed 2017-03-16 | $4.66M derived: sum of 3 quarters · filed 2017-03-16 | $3.62M 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | $12.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $14.73M derived: sum of 2 quarters · filed 2015-11-09 | $13.69M 10-Q · filed 2015-11-09 | $14.55M derived: sum of 4 quarters · filed 2016-03-15 | $17.04M 10-Q · filed 2014-11-10 | |||||||||||||
| 2014-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.57M 10-Q · filed 2015-08-10 | $2.42M derived: sum of 3 quarters · filed 2016-03-15 | $1.47M derived: sum of 4 quarters · filed 2016-03-15 | $4.91M 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | -$1.04M 10-Q · filed 2015-05-11 | -$180.00K derived: sum of 2 quarters · filed 2016-03-15 | -$1.14M derived: sum of 3 quarters · filed 2016-03-15 | -$1.19M derived: sum of 4 quarters · filed 2016-03-15 | $2.31M 10-Q · filed 2014-05-12 | |||||||||||||
| 2013-12-31 | $858.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$97.00K derived: sum of 2 quarters · filed 2016-03-15 | -$147.00K derived: sum of 3 quarters · filed 2016-03-15 | -$1.07M 10-K · filed 2016-03-15 | $3.35M 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | -$955.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$1.00M derived: sum of 2 quarters · filed 2014-11-10 | -$1.93M 10-Q · filed 2014-11-10 | -$359.00K derived: sum of 4 quarters · filed 2015-03-02 | $2.49M 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$974.00K 10-Q · filed 2014-08-11 | $596.00K derived: sum of 3 quarters · filed 2015-03-02 | -$2.17M derived: sum of 4 quarters · filed 2015-03-02 | $3.44M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | -$924.00K 10-Q · filed 2014-05-12 | $646.00K derived: sum of 2 quarters · filed 2015-03-02 | -$2.12M derived: sum of 3 quarters · filed 2015-03-02 | $833.00K derived: sum of 4 quarters · filed 2015-03-02 | $3.49M 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$1.20M derived: sum of 2 quarters · filed 2015-03-02 | $1.76M derived: sum of 3 quarters · filed 2015-03-02 | $44.00K 10-K · filed 2015-03-02 | $4.42M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | -$2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $187.00K derived: sum of 2 quarters · filed 2013-11-12 | -$1.53M 10-Q · filed 2013-11-12 | $1.27M derived: sum of 4 quarters · filed 2014-03-03 | $2.85M 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.24M 10-Q · filed 2013-08-09 | $4.04M derived: sum of 3 quarters · filed 2014-03-03 | $4.36M derived: sum of 4 quarters · filed 2014-03-03 | $5.62M 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | -$1.71M 10-Q · filed 2013-05-10 | $1.08M derived: sum of 2 quarters · filed 2014-03-03 | $1.41M derived: sum of 3 quarters · filed 2014-03-03 | $1.18M derived: sum of 4 quarters · filed 2014-03-03 | $2.66M 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $3.12M derived: sum of 2 quarters · filed 2014-03-03 | $2.89M derived: sum of 3 quarters · filed 2014-03-03 | $2.67M 10-K · filed 2014-03-03 | $4.37M 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $97.00K derived: sum of 2 quarters · filed 2012-11-09 | -$121.00K 10-Q · filed 2012-11-09 | -$4.37M derived: sum of 4 quarters · filed 2013-03-18 | $1.58M 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$447.00K 10-Q · filed 2012-08-09 | -$4.70M derived: sum of 3 quarters · filed 2013-03-18 | -$924.00K derived: sum of 4 quarters · filed 2013-03-18 | $1.25M 10-Q · filed 2011-08-04 | |||||||||||||
| 2011-03-31 | -$218.00K 10-Q · filed 2012-05-10 | -$4.47M derived: sum of 2 quarters · filed 2013-03-18 | -$695.00K derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||||
| 2010-12-31 | -$4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$477.00K derived: sum of 2 quarters · filed 2013-03-18 | -$4.29M 10-K · filed 2013-03-18 | |||||||||||||||
| 2010-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$35.00K 10-Q · filed 2011-11-04 | ||||||||||||||||
| 2010-06-30 | -$3.81M 10-Q · filed 2011-08-04 | |||||||||||||||||
| 2009-12-31 | -$6.37M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |